Register Now: Beyond EDC: Designing a Connected Data Strategy for Predictive Clinical Development
|Articles|February 10, 2023

SCOPE 2023: Primary Clinical Trial Concerns

Murray L. Aitken, SVP of IQVIA speaks about the concerns of smaller biopharma companies getting into clinical trials at the SCOPE 2023 conference in Orlando, FL.

In an interview at the 2023 SCOPE conference with ACT editor, Andy Studna, Murray L. Aitken, SVP of IQVIA discusses the concerns of smaller biopharma companies getting into clinical trials.


Related to this article

© photon_photo - © photon_photo - stock.adobe.com
Standardized measurement across five oncology centers found that clinical research coordinators rated eSource-enabled workflows positively (Overall Mean Satisfaction 5.79 of 7), with reduced manual entry and electronic data transfer earning strong marks, while perceived reduction in sponsor and monitor queries lagged as the one domain below threshold.
What Expanding AI Ecosystems Mean for Sponsor Complexity and Oversight
In this video interview, Rajneesh Patil, global head of AI, digital, and innovation in clinical development at Syneos Health, argues that CROs must act as orchestrators rather than aggregators—and that the real test of any AI ecosystem is whether it reduces sponsor coordination burden or just hands it back to them.